Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tremfya in Pityriasis Rubra Pilaris
NCT03975153Phase 2Completed
- Sponsor
- Oregon Health & Science University
- Start
- Oct 2019
- Primary completion
- Aug 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of guselkumab in pityriasis rubra pilaris (PRP), sponsored by Oregon Health & Science University. Started Oct 2019; status: completed.
02
Drugs
guselkumab
03
Conditions
pityriasis rubra pilaris (PRP)
Beyond the preview
Go deeper on NCT03975153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03975153.